Metraipolis › archive › dc_20eec3dae87b
Pridopidine Mediated Sigma-1 Receptor Activation and Therapeutic Implications in Neurodegenerative Diseases — Europe PMC PMID:42646366
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42646366
- DOI
- 10.3390/neurolint18080144
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T10:05:09.184Z
- SHA-256 of the archived text
287e732de8d26e07f50fa221c17c199b976573406c5e2f97cd9ebd4d9b637fe1- Stable URL of this page
https://metraipolis.com/documento/dc_20eec3dae87b
How to cite
Pridopidine Mediated Sigma-1 Receptor Activation and Therapeutic Implications in Neurodegenerative Diseases — Europe PMC PMID:42646366 — Europe PMC (en), https://europepmc.org/article/MED/42646366 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_20eec3dae87b (Metraipolis archive dc_20eec3dae87b, sha256 287e732de8d26e07f50fa221c17c199b976573406c5e2f97cd9ebd4d9b637fe1)
BibTeX
@misc{dc20eec3dae87b,
title = {Pridopidine Mediated Sigma-1 Receptor Activation and Therapeutic Implications in Neurodegenerative Diseases — Europe PMC PMID:42646366},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42646366},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_20eec3dae87b; sha256 287e732de8d26e07f50fa221c17c199b976573406c5e2f97cd9ebd4d9b637fe1},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42646366. Agents can read the archived copy with the MCP tool read_document.